DARE
Price:
$2.02
Market Cap:
$19.23M
Daré Bioscience, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering, developing, and bringing to market healthcare solutions specifically for women in the United States. Its comprehensive pipeline addresses a broad spectrum of needs within women's health, encompassing contraception, fertility, and both sexual and vaginal well-being. The company's initial commercial offering is XACIATO, a prescription single-dose vaginal gel designed to treat bacterial vaginosis in female patients from 12 years of age. Daré has established a licensing agreement with Organon & Co. and Organon International GmbH to commercialize this product. Beyond its marketed therapy, Daré boas...[Read more]
Industry
Biotechnology
IPO Date
2014-04-10
Stock Exchange
NASDAQ
Ticker
DARE
According to Daré Bioscience, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.22. This represents a change of -13.40% compared to the average of -2.56 of the last 4 quarters.
The mean historical PE Ratio of Daré Bioscience, Inc. over the last ten years is -3.84. The current -2.22 PE Ratio has changed 5.67% with respect to the historical average. Over the past ten years (40 quarters), DARE's PE Ratio was at its highest in in the June 2022 quarter at 63.41. The PE Ratio was at its lowest in in the December 2016 quarter at -119051.06.
Average
-3.84
Median
-1.87
Minimum
-16.10
Maximum
-0.46
Discovering the peaks and valleys of Daré Bioscience, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 586.44%
Maximum Annual PE Ratio = -0.46
Minimum Annual Increase = -89.85%
Minimum Annual PE Ratio = -16.10
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -16.10 | 146.20% |
| 2024 | -6.54 | 586.44% |
| 2023 | -0.95 | -58.00% |
| 2022 | -2.27 | -28.23% |
| 2021 | -3.16 | 114.74% |
| 2020 | -1.47 | 64.37% |
| 2019 | -0.90 | 96.47% |
| 2018 | -0.46 | -25.05% |
| 2017 | -0.61 | -89.85% |
| 2016 | -5.99 | -72.24% |
The current PE Ratio of Daré Bioscience, Inc. (DARE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.86
5-year avg
-5.80
10-year avg
-3.84
Daré Bioscience, Inc.’s PE Ratio is less than FibroBiologics, Inc. Common Stock (-0.11), less than Citius Pharmaceuticals, Inc. (-0.26), less than Leap Therapeutics, Inc. (-1.92), less than Ainos, Inc. (-0.83), less than Athira Pharma, Inc. (-0.28), less than Aspire Biopharma Holdings, Inc. (-0.63), less than Aditxt, Inc. (-0.00), greater than Palisade Bio, Inc. (-14.85), greater than Adlai Nortye Ltd. (-3.10), less than Hoth Therapeutics, Inc. (-1.51),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.11 | $1.95M | |
| -0.26 | $6.03M | |
| -1.92 | $31.86M | |
| -0.83 | $8.65M | |
| -0.28 | $26.62M | |
| -0.63 | $572.25K | |
| -0.00 | $425.00 | |
| -14.85 | $296.82M | |
| -3.10 | $547.79M | |
| -1.51 | $14.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Daré Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Daré Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Daré Bioscience, Inc.'s PE Ratio?
How is the PE Ratio calculated for Daré Bioscience, Inc. (DARE)?
What is the highest PE Ratio for Daré Bioscience, Inc. (DARE)?
What is the 3-year average PE Ratio for Daré Bioscience, Inc. (DARE)?
What is the 5-year average PE Ratio for Daré Bioscience, Inc. (DARE)?
How does the current PE Ratio for Daré Bioscience, Inc. (DARE) compare to its historical average?